PMC:7212965 / 44265-44491 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T103","span":{"begin":1,"end":6},"obj":"Body_part"},{"id":"T104","span":{"begin":117,"end":122},"obj":"Body_part"}],"attributes":[{"id":"A103","pred":"fma_id","subj":"T103","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A104","pred":"fma_id","subj":"T104","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T78","span":{"begin":1,"end":6},"obj":"Body_part"},{"id":"T79","span":{"begin":117,"end":122},"obj":"Body_part"}],"attributes":[{"id":"A78","pred":"uberon_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A79","pred":"uberon_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T229","span":{"begin":7,"end":13},"obj":"Disease"},{"id":"T230","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"T231","span":{"begin":164,"end":173},"obj":"Disease"}],"attributes":[{"id":"A229","pred":"mondo_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A230","pred":"mondo_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A231","pred":"mondo_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T336","span":{"begin":1,"end":6},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T337","span":{"begin":1,"end":6},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T338","span":{"begin":28,"end":30},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T339","span":{"begin":117,"end":122},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T340","span":{"begin":117,"end":122},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}

{"project":"LitCovid-sentences","denotations":[{"id":"T297","span":{"begin":65,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}

{"project":"LitCovid-PubTator","denotations":[{"id":"1217","span":{"begin":1,"end":13},"obj":"Disease"},{"id":"1222","span":{"begin":96,"end":112},"obj":"Gene"},{"id":"1223","span":{"begin":141,"end":149},"obj":"Species"},{"id":"1224","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"1225","span":{"begin":164,"end":173},"obj":"Disease"}],"attributes":[{"id":"A1217","pred":"tao:has_database_id","subj":"1217","obj":"MESH:D017093"},{"id":"A1222","pred":"tao:has_database_id","subj":"1222","obj":"Gene:2770"},{"id":"A1223","pred":"tao:has_database_id","subj":"1223","obj":"Tax:9606"},{"id":"A1224","pred":"tao:has_database_id","subj":"1224","obj":"MESH:C000657245"},{"id":"A1225","pred":"tao:has_database_id","subj":"1225","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" liver injury in 2.9% (1 of 35) (Supplementary Tables 2 and 3).\n\nLimitations of the Evidence on Gastrointestinal and Liver Manifestations in Patients With COVID-19 Infection\nThe individual studies in our analysis were at high "}